Mineralys Therapeutics, Inc.'s total assets for Q2 2025 were $335.72M, a decrease of -5.41% from the previous quarter. MLYS total liabilities were $22.17M for the fiscal quarter, a 65.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.